242 related articles for article (PubMed ID: 15184285)
21. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
22. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.
Wägner AM; Jorba O; Rigla M; Alonso E; Ordóñez-Llanos J; Pérez A
Acta Diabetol; 2002 Dec; 39(4):215-20. PubMed ID: 12486496
[TBL] [Abstract][Full Text] [Related]
23. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
24. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
[TBL] [Abstract][Full Text] [Related]
25. Non-cholesterol sterols in different forms of primary hyperlipemias.
Lupattelli G; Pirro M; Siepi D; Mannarino MR; Roscini AR; Vaudo G; Pasqualini L; Schillaci G; Mannarino E
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):231-6. PubMed ID: 20708389
[TBL] [Abstract][Full Text] [Related]
26. Homocysteine increases the risk associated with hyperlipidaemia.
Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
[TBL] [Abstract][Full Text] [Related]
27. Plasma homocysteine in subjects with familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; den Heijer M; Blom HJ; Stalenhoef AF
Atherosclerosis; 2003 Jan; 166(1):111-7. PubMed ID: 12482557
[TBL] [Abstract][Full Text] [Related]
28. Impact of obesity in primary hyperlipidemias.
Carmena R; Ascaso JF; Real JT
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
[TBL] [Abstract][Full Text] [Related]
29. [The use of apolipoprotein B in clinical practice to determine the risk for atherosclerosis].
Cabezas Castro M; Liem A
Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1445-8. PubMed ID: 12908345
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
[TBL] [Abstract][Full Text] [Related]
31. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
Castro Cabezas M; de Bruin TW; de Valk HW; Shoulders CC; Jansen H; Willem Erkelens D
J Clin Invest; 1993 Jul; 92(1):160-8. PubMed ID: 8100834
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
33. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
[TBL] [Abstract][Full Text] [Related]
34. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
[TBL] [Abstract][Full Text] [Related]
35. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
36. Ezetimibe treatment of pediatric patients with hypercholesterolemia.
Clauss S; Wai KM; Kavey RE; Kuehl K
J Pediatr; 2009 Jun; 154(6):869-72. PubMed ID: 19230898
[TBL] [Abstract][Full Text] [Related]
37. Plasma triglycerides and cholesterol in diabetic ketosis.
Fulop M; Eder HA
Arch Intern Med; 1989 Sep; 149(9):1997-2002. PubMed ID: 2505705
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
39. Endothelial function in familial combined hyperlipidaemia.
Ter Avest E; Holewijn S; van Tits LJ; de Wit HM; Stalenhoef AF; de Graaf J
Eur J Clin Invest; 2007 May; 37(5):381-9. PubMed ID: 17461984
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
Sattar N; Williams K; Sniderman AD; D'Agostino R; Haffner SM
Circulation; 2004 Oct; 110(17):2687-93. PubMed ID: 15492304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
